Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1993 1
1998 1
2008 1
2011 1
2012 2
2013 1
2014 1
2017 1
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Erythrocytosis, familial, 7"
Page 1
Familial risk of small intestinal carcinoid and adenocarcinoma.
Kharazmi E, Pukkala E, Sundquist K, Hemminki K. Kharazmi E, et al. Clin Gastroenterol Hepatol. 2013 Aug;11(8):944-9. doi: 10.1016/j.cgh.2013.02.025. Epub 2013 Mar 15. Clin Gastroenterol Hepatol. 2013. PMID: 23500615
Family members of patients with SIC of the carcinoid subtype had an increased risk for kidney cancer and polycythemia vera. ...Because of the rareness of this tumor, the absolute risk remains moderate even within families. Gastroenterologists could inform pat …
Family members of patients with SIC of the carcinoid subtype had an increased risk for kidney cancer and polycythemia vera. .. …
Renal transplantation in patients with familial Mediterranean fever.
Erdem E, Karatas A, Kaya C, Dilek M, Yakupoglu YK, Arık N, Akpolat T. Erdem E, et al. Clin Rheumatol. 2012 Aug;31(8):1183-6. doi: 10.1007/s10067-012-1992-6. Epub 2012 May 5. Clin Rheumatol. 2012. PMID: 22562368
Amyloidosis is the most common and devastating complication of familial Mediterranean fever (FMF). Renal transplantation is the choice of treatment of in most end-stage renal disease (ESRD). ...The clinical outcome of the patients in this cohort was similar to that of othe …
Amyloidosis is the most common and devastating complication of familial Mediterranean fever (FMF). Renal transplantation is the choic …
Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
Kridin K, Zelber-Sagi S, Comaneshter D, Batat E, Cohen AD. Kridin K, et al. J Am Acad Dermatol. 2018 Jun;78(6):1084-1089.e1. doi: 10.1016/j.jaad.2017.11.039. Epub 2017 Dec 2. J Am Acad Dermatol. 2018. PMID: 29198780
No significant associations were observed between pemphigus and acute leukemia, Hodgkin lymphoma, myelodysplastic syndrome, and polycythemia vera. LIMITATIONS: Lack of immunopathologic validation of the diagnosis of pemphigus. ...
No significant associations were observed between pemphigus and acute leukemia, Hodgkin lymphoma, myelodysplastic syndrome, and polycythe …
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Björkholm M. Landgren O, et al. Blood. 2008 Sep 15;112(6):2199-204. doi: 10.1182/blood-2008-03-143602. Epub 2008 May 1. Blood. 2008. PMID: 18451307 Free PMC article.
Previous small studies have reported familial clustering of myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). ...Using a marginal survival model, we calculated relative risks (RRs) and 95% …
Previous small studies have reported familial clustering of myeloproliferative neoplasms (MPNs), including polycythemia vera ( …
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.
Baumeister J, Maié T, Chatain N, Gan L, Weinbergerova B, de Toledo MAS, Eschweiler J, Maurer A, Mayer J, Kubesova B, Racil Z, Schuppert A, Costa I, Koschmieder S, Brümmendorf TH, Gezer D. Baumeister J, et al. Ann Hematol. 2021 Dec;100(12):2943-2956. doi: 10.1007/s00277-021-04615-8. Epub 2021 Aug 14. Ann Hematol. 2021. PMID: 34390367 Free PMC article.
The prediction of the clinical course and progression remains difficult and new therapeutic modalities are required. ...Differentially regulated genes that might be utilized as diagnostic/prognostic markers were identified, such as AREG, CYBB, DNTT, TIMD4, VC …
The prediction of the clinical course and progression remains difficult and new therapeutic modalities are required. ...Differ …
Nonendocrine cancers associated with benign and malignant parathyroid tumors.
Fallah M, Kharazmi E, Sundquist J, Hemminki K. Fallah M, et al. J Clin Endocrinol Metab. 2011 Jul;96(7):E1108-14. doi: 10.1210/jc.2011-0099. Epub 2011 Apr 27. J Clin Endocrinol Metab. 2011. PMID: 21525164
Risk of parathyroid adenoma significantly increased after polycythemia vera (3.9) and malignancy in small intestine (3.5), kidney (2.8), nervous system (2.0), prostate (1.5), skin (melanoma 1.5), bladder (1.4), and breast (women 1.2). ...CONCLUSIONS: Parathyroid adenoma ca …
Risk of parathyroid adenoma significantly increased after polycythemia vera (3.9) and malignancy in small intestine (3.5), kidney (2. …
Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations.
Saritaş Nakip Ö, Yıldız Y, Tokatlı A. Saritaş Nakip Ö, et al. J Pediatr Endocrinol Metab. 2020 May 24;33(6):721-728. doi: 10.1515/jpem-2019-0413. J Pediatr Endocrinol Metab. 2020. PMID: 32447331
Investigating the relationships between the patient outcomes and ammonia levels were the secondary outcomes. Eighty five patients from 79 families, diagnosed with UCD at a single metabolic referral center between 1979 and 2017, were included. ...The peak ammonia levels wer …
Investigating the relationships between the patient outcomes and ammonia levels were the secondary outcomes. Eighty five patients from 79 …
Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.
Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A; French Group of Familial Myeloproliferative Disorders. Malak S, et al. Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):170-6. doi: 10.1016/j.bcmd.2012.06.004. Epub 2012 Jul 19. Blood Cells Mol Dis. 2012. PMID: 22818858
The long-term evolution of familial myeloproliferative neoplasms was studied in 93 families with 227 subjects including 97 with polycythemia vera (PV), 105 essential thrombocythemia (ET), 14 primary myelofibrosis (PMF) and 11 chronic myeloid leukemia (CML). . …
The long-term evolution of familial myeloproliferative neoplasms was studied in 93 families with 227 subjects including 97 wit …
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.
Rondelli D, Goldberg JD, Isola L, Price LS, Shore TB, Boyer M, Bacigalupo A, Rambaldi A, Scarano M, Klisovic RB, Gupta V, Andreasson B, Mascarenhas J, Wetzler M, Vannucchi AM, Prchal JT, Najfeld V, Orazi A, Weinberg RS, Miller C, Barosi G, Silverman LR, Prosperini G, Marchioli R, Hoffman R. Rondelli D, et al. Blood. 2014 Aug 14;124(7):1183-91. doi: 10.1182/blood-2014-04-572545. Epub 2014 Jun 24. Blood. 2014. PMID: 24963042 Free PMC article. Clinical Trial.
From 2007 to 2011, 66 patients with primary myelofibrosis or myelofibrosis (MF) preceded by essential thrombocythemia or polycythemia vera were enrolled into a prospective phase 2 clinical trial of reduced-intensity allogeneic hematopoietic stem cell transplantation (AHSCT …
From 2007 to 2011, 66 patients with primary myelofibrosis or myelofibrosis (MF) preceded by essential thrombocythemia or polycythemia …
Epidemiological data in polycythaemia vera: a study of 842 cases.
Najean Y, Rain JD, Billotey C. Najean Y, et al. Hematol Cell Ther. 1998 Aug;40(4):159-65. Hematol Cell Ther. 1998. PMID: 9766920
A surprising excess of former blood donors (20.7% of the PV cases, compared to 8% estimated in the reference population) was observed. Only a few cases of familial myeloproliferative diseases and occurence of leukemia in the family of our patients have been observed …
A surprising excess of former blood donors (20.7% of the PV cases, compared to 8% estimated in the reference population) was observed. Only …
12 results